President Donald Trump made good on his campaign promises to kick off his second term in office with a tidal wave of ...
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
The Health and Human Services Department won’t issue health advisories, reports or other materials until further notice, with ...
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
And remember, Medicare provides access to about 8,000 drugs ... but what I will tell you is there is a core of personnel at HHS, regardless of administration, that has done dramatically important ...
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
The exact scope and duration is clear, and one question is what will happen to release of CDC data that employers and insurers use in pricing.
Additional 15 drugs are taken by over 5 million Americans and treat cancer, type 2 diabetes, asthma, and more WASHINGTON, D.C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback